NetScientific - PDS agrees to merge with Edge Therapeutics
In late November 2018, NetScientific announced that its portfolio company PDS Biotechnology and Edge Therapeutics (NASDAQ: EDGE) will merge. The...
50 Views
NetScientific - Fosun Pharma investing in Glycotest
NetScientific announced the completion of a $10m Series A funding for Glycotest with Fosun Pharma, a Chinese pharmaceutical company with a market...
51 Views
NetScientific - Steady as she goes
NetScientific recently announced half-year results for 2018, with incremental progress continuing to be made, although we are yet to see that...
34 Views
NetScientific - Advancing on multiple fronts to commercialisation
NetScientific recently announced full-year results for 2017. It was a year of progress for the company, which is carrying forward into 2018. In...
89 Views
NetScientific - Clinical and commercial progress continues
In January Glycotest announced that it had completed a 149-person Chinese retrospective study of its test for hepatocellular carcinoma (HCC). It...
35 Views
No more insights